“Endocannabinoid System Manipulation in the Treatment of Scleroderma:
A New Therapeutic Strategy?"
Robert Spiera, MD
Patient Education Forum - HSS
About Dr. Spiera:
Dr. Robert Spiera obtained his medical degree from Yale University School of Medicine, completing his Residency in Internal Medicine and Fellowship training in Rheumatology from New York Presbyterian Hospital- Cornell Campus.
He is the Director of the Vasculitis and Scleroderma Program at the Hospital for Special Surgery, and a Professor of Clinical Medicine at Weill Cornell Medical College. Dr. Spiera is the principal investigator in several clinical trials and observational studies in scleroderma and has collaborated with basic investigators on translational studies. He has authored over 100 publications relating to scleroderma, vasculitis, and other rheumatic diseases. He is an active clinician who cares for patients with scleroderma as well as other complex rheumatologic illnesses.
Dr. Spiera currently serves as the Chair of Tri-State Medical Advisory Board as well as on the National Scleroderma Foundation’s Medical and Scientific Advisory Board.
The information presented on this site is intended for educational purposes only. Neither the featured speakers, nor the Scleroderma Foundation, nor Starlight Productions ( the producers of these videos) suggest, recommend or endorse any specific treatment for any individual. Patients are advised consult their own health
care providers for treatment options.
Back to Research Back to All Speakers
Back to All Topics